| Followers | 129 |
| Posts | 2150 |
| Boards Moderated | 1 |
| Alias Born | 12/27/2007 |
Monday, January 13, 2020 9:40:22 AM
CANF =MC $9 M --NASH P2 DATA imminent ($25+ BILLION MKT with NO approved treatment to date = Could be more than just a 10 bagger aMEGA opp here guys .GL
https://ir.canfite.com/press-releases/detail/881/can-fite-ceo-issues-letter-to-shareholders
Q1 2020: Topline results from NASH Phase II study expected
Advanced stage clinical pipeline positioned to potentially generate more non-dilutive funding through out-licensing distribution agreements
Two Phase III studies enrolling in psoriasis and rheumatoid arthritis
https://ir.canfite.com/press-releases/detail/881/can-fite-ceo-issues-letter-to-shareholders
Q1 2020: Topline results from NASH Phase II study expected
Advanced stage clinical pipeline positioned to potentially generate more non-dilutive funding through out-licensing distribution agreements
Two Phase III studies enrolling in psoriasis and rheumatoid arthritis
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
